Drug Trial Radar · NCT06904313
Ultralow Dose PET Imaging for PSMA Expression
Last checked: Nov 19, 2026Latest source record: Jun 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
May 12, 2025
Primary completion
Jun 30, 2030
Study completion Jun 30, 2030
Sponsor
- Lead sponsor
- Akiva MintzAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 1, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 120 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to evaluate an investigational ultralow dose PET imaging technique for prostate cancer detection and monitoring. The main question it aims to answer is: Can the investigators optimize the timing, scan duration, and image reconstruction to reduce the radiation dose 10-100 fold of the current clinical standard? Participants will be injected with a radioactive tracer called 18F-DCFPyL and be imaged on a new type of high sensitivity PET scanner for up to 3 hours
Conditions
- Healthy Volunteer
- Prostate CA
Interventions
Piflufolastat F18Drug
Participants will be injected with Piflufolastat F18 and imaged for up to 3 hours on a PET scanner
Primary outcomes
What the sponsor says the trial is designed to measure.
- Signal-to-Noise Ratio (SNR)Time frame: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.
- Contrast-to-Noise Ratio (CNR)Time frame: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.
- Coefficient of Variation (COV)Time frame: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.
- Spatial Resolution (Full Width at Half Maximum - FWHM)Time frame: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.
- Target-to-Background Ratio (TBR)Time frame: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.
- Qualitative Image Quality Score (Likert Scale)Time frame: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.
- Inter-reader Agreement (Weighted Kappa Statistics)Time frame: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Nuclear Imaging Institute
Englewood, New Jersey · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.